167 related articles for article (PubMed ID: 33882515)
21. The role of myeloid-derived suppressor cells in the pathogenesis of rheumatoid arthritis; anti- or pro-inflammatory cells?
Rajabinejad M; Salari F; Gorgin Karaji A; Rezaiemanesh A
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):4149-4158. PubMed ID: 31698956
[TBL] [Abstract][Full Text] [Related]
22. CD33
Sun Y; Shao J; Jiang F; Wang Y; Yan Q; Yu N; Zhang J; Zhang J; Li M; He Y
Am J Reprod Immunol; 2019 Jan; 81(1):e13067. PubMed ID: 30375700
[TBL] [Abstract][Full Text] [Related]
23. Myeloid-Derived Suppressor Cells and Their Potential Application in Transplantation.
Scalea JR; Lee YS; Davila E; Bromberg JS
Transplantation; 2018 Mar; 102(3):359-367. PubMed ID: 29189485
[TBL] [Abstract][Full Text] [Related]
24. [Circulating Myeloid Suppressor Cells and Their Role in Tumour Immunology].
Pilatova K; Budinská E; Bensciková B; Nenutil R; Šefr R; Fedorová L; Hanáková B; Brychtová V; Zdražilová Dubská L
Klin Onkol; 2017; 30(Supplementum1):166-169. PubMed ID: 28471197
[TBL] [Abstract][Full Text] [Related]
25. An In Vivo Mouse Model for Chronic Inflammation-Induced Immune Suppression: A "Factory" for Myeloid-Derived Suppressor Cells (MDSCs).
Ben-Meir K; Twaik N; Meirow Y; Baniyash M
Curr Protoc; 2022 Sep; 2(10):e558. PubMed ID: 36239438
[TBL] [Abstract][Full Text] [Related]
26. Myeloid-derived suppressor cells: The green light for myeloma immune escape.
Malek E; de Lima M; Letterio JJ; Kim BG; Finke JH; Driscoll JJ; Giralt SA
Blood Rev; 2016 Sep; 30(5):341-8. PubMed ID: 27132116
[TBL] [Abstract][Full Text] [Related]
27. [Research advances of myeloid-derived suppressor cells in sepsis-induced immunosuppression].
Peng Z; Xu J; He Y; Sun D; Shang Y
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2022 Jun; 34(6):666-669. PubMed ID: 35924528
[TBL] [Abstract][Full Text] [Related]
28. Age-related expansion and increased osteoclastogenic potential of myeloid-derived suppressor cells.
Li Z; Zhao Y; Chen Z; Katz J; Michalek SM; Li Y; Zhang P
Mol Immunol; 2021 Sep; 137():187-200. PubMed ID: 34274794
[TBL] [Abstract][Full Text] [Related]
29. Early Activation of Myeloid-Derived Suppressor Cells Participate in Sepsis-Induced Immune Suppression via PD-L1/PD-1 Axis.
Ruan WS; Feng MX; Xu J; Xu YG; Song CY; Lin LY; Li L; Lu YQ
Front Immunol; 2020; 11():1299. PubMed ID: 32719675
[No Abstract] [Full Text] [Related]
30. MDSCs in sepsis-induced immunosuppression and its potential therapeutic targets.
Zhang W; Fang X; Gao C; Song C; He Y; Zhou T; Yang X; Shang Y; Xu J
Cytokine Growth Factor Rev; 2023 Feb; 69():90-103. PubMed ID: 35927154
[TBL] [Abstract][Full Text] [Related]
31. Roles of Myeloid-Derived Suppressor Cell Subpopulations in Autoimmune Arthritis.
Li M; Zhu D; Wang T; Xia X; Tian J; Wang S
Front Immunol; 2018; 9():2849. PubMed ID: 30564242
[TBL] [Abstract][Full Text] [Related]
32. Human prosthetic joint infections are associated with myeloid-derived suppressor cells (MDSCs): Implications for infection persistence.
Heim CE; Vidlak D; Odvody J; Hartman CW; Garvin KL; Kielian T
J Orthop Res; 2018 Jun; 36(6):1605-1613. PubMed ID: 29139571
[TBL] [Abstract][Full Text] [Related]
33. Granulocyte-Macrophage Colony-Stimulating Factor Modulates Myeloid-Derived Suppressor Cells and Treg Activity in Decompensated Cirrhotic Patients With Sepsis.
Sehgal R; Maiwall R; Rajan V; Islam M; Baweja S; Kaur N; Kumar G; Ramakrishna G; Sarin SK; Trehanpati N
Front Immunol; 2022; 13():828949. PubMed ID: 35720398
[TBL] [Abstract][Full Text] [Related]
34. Burn injury is associated with an infiltration of the wound site with myeloid-derived suppressor cells.
Schwacha MG; Scroggins SR; Montgomery RK; Nicholson SE; Cap AP
Cell Immunol; 2019 Apr; 338():21-26. PubMed ID: 30902343
[TBL] [Abstract][Full Text] [Related]
35. Myeloid-Derived Suppressor Cells in
Fresno M; Gironès N
Front Cell Infect Microbiol; 2021; 11():737364. PubMed ID: 34513737
[TBL] [Abstract][Full Text] [Related]
36. Functional Assays Evaluating Immunosuppression Mediated by Myeloid-Derived Suppressor Cells.
Reuven O; Mikula I; Ashkenazi-Preiser H; Twaik N; Ben-Meir K; Meirow Y; Daniel L; Kariv G; Kurd M; Baniyash M
Curr Protoc; 2022 Oct; 2(10):e557. PubMed ID: 36282094
[TBL] [Abstract][Full Text] [Related]
37. Myeloid-derived suppressor cells evolve during sepsis and can enhance or attenuate the systemic inflammatory response.
Brudecki L; Ferguson DA; McCall CE; El Gazzar M
Infect Immun; 2012 Jun; 80(6):2026-34. PubMed ID: 22451518
[TBL] [Abstract][Full Text] [Related]
38. Interferon regulatory factor 4 (IRF4) controls myeloid-derived suppressor cell (MDSC) differentiation and function.
Nam S; Kang K; Cha JS; Kim JW; Lee HG; Kim Y; Yang Y; Lee MS; Lim JS
J Leukoc Biol; 2016 Dec; 100(6):1273-1284. PubMed ID: 27601624
[TBL] [Abstract][Full Text] [Related]
39. Lipid Metabolism in Tumor-Associated Myeloid-Derived Suppressor Cells.
Liu W; Song H; Li X; Ren D; Ding S; Li Y
Adv Exp Med Biol; 2021; 1316():103-115. PubMed ID: 33740246
[TBL] [Abstract][Full Text] [Related]
40. Myeloid-derived suppressor cell function and epigenetic expression evolves over time after surgical sepsis.
Hollen MK; Stortz JA; Darden D; Dirain ML; Nacionales DC; Hawkins RB; Cox MC; Lopez MC; Rincon JC; Ungaro R; Wang Z; Wu Q; Brumback B; Gauthier ML; Kladde M; Leeuwenburgh C; Segal M; Bihorac A; Brakenridge S; Moore FA; Baker HV; Mohr AM; Moldawer LL; Efron PA
Crit Care; 2019 Nov; 23(1):355. PubMed ID: 31722736
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
